Article information
Full text is only aviable in PDF
References
[1.]
R.D. Sweet.
An acute febrile neutrophilic dermatosis.
Br J Dermatol, 76 (1964), pp. 349-356
[2.]
P. Hilliquin, J.P. Marre, C. Cormier, M. Renoux, C.J. Menkes, A. Puissant.
Sweet's syndrome and monoarthritis in a human inmunodeficiency virus-positive patient.
Arthritis Rheum, 35 (1992), pp. 484-486
[3.]
T.G. Berger, A. Dhar, T.H. Mc Calmont.
Neutrophilic dermatoses in HIV infection.
J Am Acad Dermatol, 31 (1994), pp. 1045-1047
[4.]
S. Bevilacqua, P. Hermans, Y. Van Laethem, J. Demaubeuge, N. Clumeck.
Sweet's syndrome in an HIV-infected patient.
AIDS, 13 (1999), pp. 728-729
[5.]
R.C. Brady, J. Morris, B.L. Connelly, S. Boiko.
Sweet's syndrome as an initial manifestation of pediatric human immunodeficiency virus infection.
Pediatrics, 104 (1999), pp. 1142-1144
[6.]
P. Del Giudice, F. Vandenbos, C. Perrin, E. Bernard, L. Marq, P. Dellamonica.
Sweet's syndrome following abacavir therapy.
J Am Acad Dermatol, 51 (2004), pp. 474-475
[7.]
R. Benelli, A. Barbero, S. Ferrini, M. Cassatella, F. Bussolino, C. Tacchetti, et al.
Human inmunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tatmediated pathogenesis.
J Infect Dis, 182 (2000), pp. 1643-1651
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
